The signaling events that are induced by inflammatory mediators, in an osteoarthritis context, lead to the NF-κB activation and to pro-inflammatory gene expression as previously mentioned, but this is also the case in IBD [67]. This evidence concerns the gene NFKB1 and inflammatory bowel disease.